User profiles for Brown, D.R.
 |
Progress in adsorption-based CO 2 capture by metal–organic frameworks
J Liu, PK Thallapally, BP McGrail, DR Brown… - Chemical Society …, 2012 - pubs.rsc.org
… Dr Liu has published over 15 peer reviewed papers and presented several talks in four
consecutive AlChE Annual Conference. He is also a member of the AIChE and the Sigma Xi …
consecutive AlChE Annual Conference. He is also a member of the AIChE and the Sigma Xi …
Blind equalization using the constant modulus criterion: A review
…, TJ Endres, JD Behm, DR Brown… - Proceedings of the …, 1998 - ieeexplore.ieee.org
This paper provides a tutorial introduction to the constant modulus (CM) criterion for blind
fractionally spaced equalizer (FSE) design via a (stochastic) gradient descent algorithm such …
fractionally spaced equalizer (FSE) design via a (stochastic) gradient descent algorithm such …
Impact and effectiveness of the quadrivalent human papillomavirus vaccine: a systematic review of 10 years of real-world experience
…, N Muñoz, SL Block, DR Brown… - Reviews of Infectious …, 2016 - academic.oup.com
Prophylactic human papillomavirus (HPV) vaccination programs constitute major public
health initiatives worldwide. We assessed the global effect of quadrivalent HPV (4vHPV) …
health initiatives worldwide. We assessed the global effect of quadrivalent HPV (4vHPV) …
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine …
DR Brown, SK Kjaer, K Sigurdsson… - The Journal of …, 2009 - academic.oup.com
BackgroundHuman papillomavirus (HPV)–6/11/16/18 vaccine reduces the risk of HPV-6/11/16/18–related
cervical intraepithelial neoplasia (CIN) 1–3 or adenocarcinoma in situ (AIS). …
cervical intraepithelial neoplasia (CIN) 1–3 or adenocarcinoma in situ (AIS). …
The cellular prion protein binds copper in vivo
The normal cellular form of prion protein (PrP C ) is a precursor to the pathogenic protease-resistant
forms (PrP Sc ) believed to cause scrapie, bovine spongiform encephalopathy (BSE) …
forms (PrP Sc ) believed to cause scrapie, bovine spongiform encephalopathy (BSE) …
[BOOK][B] Statistical principles in experimental design
BJ Winer, DR Brown, KM Michels - 1971 - scholar.archive.org
1.1 Basic terminology in sampling 4 1.2, Basic terminology in statistical estimation 7 1.3
Basic terminology in testing statistical hypotheses 10 1.4 Testing hypotheses on means—a …
Basic terminology in testing statistical hypotheses 10 1.4 Testing hypotheses on means—a …
A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women
DR Brown, ML Shew, B Qadadri… - Journal of Infectious …, 2005 - academic.oup.com
Background We performed a study to better characterize the natural history of genital human
papillomavirus (HPV) infection in a cohort of closely followed adolescent women. Methods …
papillomavirus (HPV) infection in a cohort of closely followed adolescent women. Methods …
Role of microglia and host prion protein in neurotoxicity of a prion protein fragment
DR Brown, B Schmidt, HA Kretzschmar - Nature, 1996 - nature.com
THE prion protein PrP c is a glycoprotein of unknown function 1 normally found in neurons 2
and glia 3 . It is involved in diseases such as bovine spongiform encephalopathy (BSE), …
and glia 3 . It is involved in diseases such as bovine spongiform encephalopathy (BSE), …
[HTML][HTML] A controlled trial of a human papillomavirus type 16 vaccine
…, KA Ault, CM Wheeler, DR Brown… - … England Journal of …, 2002 - Mass Medical Soc
Background Approximately 20 percent of adults become infected with human papillomavirus
type 16 (HPV-16). Although most infections are benign, some progress to anogenital cancer…
type 16 (HPV-16). Although most infections are benign, some progress to anogenital cancer…
Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo …
…, SE Olsson, M Steinwall, DR Brown… - The lancet …, 2005 - thelancet.com
Background A randomised double-blind placebo-controlled phase II study was done to
assess the efficacy of a prophylactic quadrivalent vaccine targeting the human papillomavirus (…
assess the efficacy of a prophylactic quadrivalent vaccine targeting the human papillomavirus (…